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Abstract A chemically synthesized gene coding for a Cucurbita 
maxima trypsin inhibitor modified at position P'3 (Met8--~ Leu 
CMTI I), i.e. at the third position downstream of the reactive site 
bond (ArgS-lle), was cloned into a derivative of the plasmid 
pAED4 that utilizes a T7 expression system. The gene was ex- 
pressed in Escherichia coli as a fusion protein that accumulates 
in inclusion bodies. After reduction and CNBr cleavage of the 
fusion protein followed by oxidative refolding and reverse-phase 
HPLC, about 5 mg of pure protein was obtained per I of cell 
culture. Association constants of recombinant Leu-8-CMTI I 
with bovine ~l-trypsin and human cathepsin G are the same, within 
experimental error, as for CMTI I isolated from a natural source. 
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I. Introduction 
Proteinases play a central role in such basic physiological 
processes as posttranslational processing, fertilization, pro- 
hormone processing, complement activation, blood coagula- 
tion, and fibrinolysis [1]. Proteinases have also been implicated 
in certain diseases including trauma, tumor metastasis, emphy- 
sema, and arthritis [2]. An essential mechanism of their regula- 
tion involves inactivation of proteinases by forming complexes 
with protein inhibitors. The structure and mechanism of action 
of inhibitors have been extensively studied [3,4]. 
A large group of serine proteinase inhibitors has been identi- 
fied in squash seeds [5]. The compact and very rigid structure 
of these small proteins consists of 27 32 amino acid residues, 
stabilized by three disulfide bridges. Because of their small size 
and rigidity, the squash inhibitors provide an excellent model 
for studying serine protease-protein inhibitor interaction. 
For mechanistic studies extensive comparative binding ex- 
periments using a large variety of single or multiple mutants are 
the most informative. Many such analogues of squash inhib- 
itors have been synthesized by the solid-phase method and their 
association constants with trypsin, elastase, and chymotrypsin 
have been measured [5]. Nevertheless, chemical synthesis of 
polypeptide chains of about 30 amino acid residues is time 
consuming and expensive. The already high cost of synthesis 
would become exorbitant in the case of 15N- and/or 13C-en- 
riched proteins required for multidimensional NMR experi- 
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ments; these are particularly desirable in conformational stud- 
ies of inhibitor-enzyme complexes. The best way to solve the 
problem is to apply gene cloning and site-directed mutagenesis 
techniques. 
In this paper we describe an efficient expression system for 
a squash inhibitor in E. coli. We realized that there is little 
likelihood of achieving significant production of such a small 
protein by direct cytoplasmic expression. The final yield of 
small gene proteins expressed in E. coli is usually very low, 
mostly due to metabolic instability of the expression products. 
A successful approach to avoid this problem is to clone the 
protein gene fused with a sequence coding for a long, hydro- 
phobic polypeptide chain leading the recombinant protein to 
form inclusion bodies. 
The plasmid used by us, a derivative of pAED4 [6], has been 
used previously to produce recombinant proteins [7,8] and pep- 
tides [9] in E. coli. The plasmid utilizes a T7 expression system 
from the pET3a plasmid [10] and includes an FI replication 
origin to allow for single-stranded mutagenesis. The gene for 
CMTI I is preceded by the sequence containing a part of the 
leader region and a part of trpE gene of the trp operon of 
E. coli. This sequence codes for LE1413 polypeptide [11] - an 
effective leader of fusion proteins into inclusion bodies [12]. All 
methionines and cysteines in the LE1413 sequence have been 
replaced by alanines to facilitate purification procedure [13]. 
In the system used by us the desired biological material is 
obtained from the fusion protein by CNBr cleavage at Met 
residue. The sequence of Cucurbita maxima trypsin inhibitor I
(CMTI I) the best known representative of the squash inhib- 
itor family contains a single Met residue at position 8. We 
have substituted it by leucine (see Fig. 1) as a residue which is 
similar to methionine. 
2. Materials and methods 
All chemicals used were of the highest purity grade. Restriction 
enzymes, T4 DNA ligase, T4 polynucleotide kinase and a dideoxy 
sequencing kit were from Amersham. Plasmid pAED4 was a generous 
gift from Professor P.S.Kim. A sample of native CMTI I was isolated 
from figleaf gourd (C. ficifolia) as described [14]. Bovine fl-trypsin was 
obtained according to the method of Liepnicks and Light [15]. Human 
cathepsin G was a kind gift from Dr. W. Watorek. 
2.1. Plasmid construction 
The nucleotide sequences coding for Leu-8-CMTI I was programmed 
according to its respective amino acid sequence (Fig. 1) with the codon 
preferences tablished for E. coli [16]. Oligonucleotides u ed for syn- 
thesis were purchased from the Center for Molecular and Macromol- 
ecular Research of the Polish Academy of Sciences, Lodz. All oligonu- 
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cle~,tides, except erminal ones, were 5'-phosphorylated with T4 poly- 
nucleotide kinase, annealed and ligated in a single step using standard 
procedures [17]. A ligation product of the expected size was isolated 
from polyacrylamide g ls and cloned into HindIIIlBamHI sites of the 
derivative of pAED4 plasmid [6] in frame with the sequence coding for 
LL1413 polypeptide. The sequence of the gene was confirmed by the 
dideoxy sequencing method. 
22 Protein expression and purification 
t ;xpression and cyanogen bromide cleavage of the protein were car- 
ried out, with small modifications, as described [13]. E. coli strain 
BI ! 1 (DE3)-pLys(S) cells were transformed with pAED4 plasmid bear- 
in~ the CMTI I gene. The transformed cells were grown from overnight 
cul ures at 37°C in Luria groth containing 100/~g/ml ampicillin and 30 
/~g ml chloramphenicol. The cells were induced at OD590 = 1.0 with 0.4 
mM isopropyl-fl-o-thiogalactopyranoside (IPTG) and harvested after 
2.5 h. The cells were lysed by freezing, followed by sonication i  50 mM 
Tr:~, pH 8.7, 15% glycerol, 100 mM MgCI2, 10 mM MnC12, 10/lg/ml 
D?.4Ase I and centrifuged. The pellet was resuspended in 50 mM Tris, 
pI-t 8.7, 1% Nonidet (NP40), 1% deoxycholic acid, 1 mM EDTA, 200 
mM NaC1, sonicated and centrifuged. 
"he pellet was dissolved in 6 M GuHC1, 50 mM Tris, pH 8.7, 10 mM 
ox dized glutathione, and incubated for 15 min at room temperature. 
Nt ~t, the samples were diluted 10-fold with water and centrifuged. The 
pe iet was suspended in 1(I ml of 70% formic acid and 200 mg of CNBr 
wa ; added. After 2.5 h the reaction mixture was spun under vacuum 
fo 4 h, 10-fold diluted with water, and freeze-dried. The lyophilizate 
w~ ; dissolved in 6 M GuHC1, 0.1 M dithiotreitol, 0.1 M Tris, pH 8.7, 
an I dialyzed against 5% acetic acid. The supernatant was mixed with 
an equal volume of Tris (0.3 M), KCI (0.6 M), EDTA (3 mM), oxidized 
gh tathione (10 mM), pH 9.0, giving final pH 8.5, and incubated over- 
ni~ hr. The native form of inhibitor was purified on a semi-preparative 
V) tac C18 column in acetonitrile/water gradient in the presence of 
tri luoroacetic acid (0.1%1. 
3. Results 
Fhe final yield of the Leu-8-CMTI I was estimated spectro- 
pl~otomerically from its Tyr27 absorption to be about 5 rag/1 
ot culture. The molecular mass of the resulting material was 
fo md by laser desorption mass spectrometry to be 3257 + 3 
wi ich is in excellent agreement with the calculated value, 3257. 
T1 e HPLC elution profile of the mixture of CMTI  I and Leu- 
8-,2MTI I indicates that the latter elutes at a slightly higher 
co lcentration of acetonitrile. 
In order to check the effect of Met8~Leu substitution on 
th : energy of association with proteinases, we determined asso- 
ck tion constants with two different enzymes: bovine fl-trypsin 
ard human cathepsin G. In both cases the association constants 
w, re the same (within experimental error) as for the wild-type 
in libitor (Table 1). 
4. Discussion 
~n attempt o produce in an E. coli system a trypsin inhibitor 
ve'y close to CMTI  I was made previously by Chen at al. [18] 
1 l0  
Trp Met Arg  Val Cys Pro Arg Ile Leu Leu GIu Cys Lys Lys Asp Set ASp 
GCTT TGG ATG CGT GTT TGC CCG CGT ATC CTG CTG GAA TGC AAA AAA GAC TCT GAC 
A ACC TAC GCA CAA ACG GGC GCA TAG GAC GAC CTT ACG TTT TTT CTG AGA CTG 
i nd  ~IX 
20 29 
ys Leu Ala Glu Cys Val Cys Leu Glu His Gly Tyr Cys Gly  ter  ter 
'GC CTG GCT GAA TGC GTT TGC CTG GAA CAC GGT TAC TGC GGT TAA TAG 3' 
~CG GAC CGA CTT ACG CAA ACG GAC CTT GTG CCA ATG ACG CCA ATT ATC CTAG 
Fig. 1. Gene and amino acid sequences of Leu-8-CMTI I. 
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Table 1 
Comparison of association and hydrolysis constants for CMTI I and 
Leu-8-CMTI I 
Inhibitor Association constant (M -~) Hydrolysis constant 
fl-trypsin cathepsin G 
CMTI 3.3x10 H 1.7x108 1.84 
Leu-8-CMTI1 1.2xl0 II 1.2xl08 4.74 
Association constants were determined in 0.1 M Tris, 20 mM CaCI2, 
0.01% Triton X100, pH 8.3, at 22°C as described by Otlewski and 
Zbyryt [22]. In the case of cathepsin G the buffer additionally contained 
500 mM NaCI. Hydrolysis constants of the reactive site peptide bond 
Arg5-11e were determined in 100 mM Mes, pH 6.0, 20 mM CaCI2. 
2 mol% of bovine fl-trypsin were added to a 0.1/~M solution of the in- 
hibitor and the progress of hydrolysis was monitored using a C18 
,uBondapak reversed-phase column as described [22]. 
using the plasmid pWR590-1. The results were not satisfactory. 
The total yield of purified, active inhibitor was only about 200 
/~g per 1 of cell culture. As our results have shown, using a 
plasmid that utilizes a T7 expression system, a much higher 
yield can be obtained (5 mg/l), high enough, in fact, to keep at 
a reasonable level the cost of production of ~SN- and/or 13C- 
labeled protein. 
MetS--* Leu substitution does not have any noticeable ffect 
on the activity of CMTI  I inhibitor (see Table 1) despite the fact 
that methionine at position 8 is strongly conserved in the 
squash inhibitors. Of 24 unique amino acid sequences of squash 
inhibitors 22 contain Met and two sequences contain Lys 5. Our 
data are in agreement with the X-ray structure of CMTI  I- 
bovine trypsin complex showing that Met8 is not in contact 
with the proteinase [19]. 
We find, however, a significant effect of the substitution on 
the hydrolysis constant value. The Khyd is increased 2.6-fold 
upon substitution. Unlike the association constant, this param- 
eter does not describe an enzyme-inhibitor interaction, but is 
an exclusive property of an inhibitor. An increased value ofKhy d 
suggests that either the intact form of Leu-8-CMTI I has in- 
creased free energy compared to the wild-type inhibitor, or that 
the cleaved form of Leu-8-CMTI I is stabilized compared to the 
cleaved form of the wild type CMTI  I. At present the first 
possibility cannot be excluded. The conservative substitution 
lle6---~Leu in homologous EETI II inhibitor resulted 
in a significant increase of the binding loop disorder [20]. On 
the other hand, the side chain of Met8 does not contact any 
other part of the inhibitor, either in the crystal [19] or in the 
solution structure [21]. It thus seems more likely that upon 
reactive site hydrolysis Leu8 undergoes an interaction or inter- 
actions which are absent or weaker in the Met8 CMTI  I. 
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